PGR and breast cancer: In pre-menopausal women with ER- and/or PR-positive breast cancer, SNPs in CYP2B6 such as CYP2B6 rs4802101 (T/T) and CYP2B6 rs3211371 (T/C) have been associated with adverse prognosis [61].